1 Influenza Virus Vaccine (H1N1) Market Overview |
|
1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1) |
|
1.2 Influenza Virus Vaccine (H1N1) Segment by Type |
|
| 1.2.1 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2021-2026) | |
| 1.2.2 Intramuscular Vaccine | |
| 1.2.3 Nasal Spray Vaccine | |
1.3 Influenza Virus Vaccine (H1N1) Segment by Application |
|
| 1.3.1 Influenza Virus Vaccine (H1N1) Sales Comparison by Application: 2020 VS 2026 | |
| 1.3.2 3 To 10 Years Old | |
| 1.3.3 10 To 18 Years Old | |
| 1.3.4 Above 18 Years Old | |
| 1.3.5 Other | |
1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts |
|
| 1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2015-2026 | |
| 1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2015-2026 | |
| 1.4.3 Influenza Virus Vaccine (H1N1) Market Size by Region: 2020 Versus 2026 | |
2 Global Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers |
|
2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2015-2020) |
|
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020) |
|
2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2015-2020) |
|
2.4 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type |
|
2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends |
|
| 2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate | |
| 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue | |
| 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) | |
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans |
|
2.7 Primary Interviews with Key Influenza Virus Vaccine (H1N1) Players (Opinion Leaders) |
|
3 Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region |
|
3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2015-2020 |
|
3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2015-2020 |
|
3.3 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country |
|
| 3.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.3.2 North America Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.3.3 U.S. | |
| 3.3.4 Canada | |
3.4 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country |
|
| 3.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.4.2 Europe Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.4.3 Germany | |
| 3.4.4 France | |
| 3.4.5 U.K. | |
| 3.4.6 Italy | |
| 3.4.7 Russia | |
3.5 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region |
|
| 3.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region | |
| 3.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region | |
| 3.5.3 China | |
| 詳^情：http://www.miaohuangjin.cn/0/91/Global-Influenza-Virus-Vaccine-H1N1-Industry-In-Depth-Research-and-Trends-Analysis-Repor.html | |
| 3.5.4 Japan | |
| 3.5.5 South Korea | |
| 3.5.6 India | |
| 3.5.7 Australia | |
| 3.5.8 Taiwan, China | |
| 3.5.9 Indonesia | |
| 3.5.10 Thailand | |
| 3.5.11 Malaysia | |
| 3.5.12 Philippines | |
| 3.5.13 Vietnam | |
3.6 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country |
|
| 3.6.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.6.2 Latin America Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.6.3 Mexico | |
| 3.6.3 Brazil | |
| 3.6.3 Argentina | |
3.7 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country |
|
| 3.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country | |
| 3.7.3 Turkey | |
| 3.7.4 Saudi Arabia | |
| 3.7.5 UAE | |
4 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Type |
|
4.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2015-2020) |
|
4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2015-2020) |
|
4.3 Global Influenza Virus Vaccine (H1N1) Price Market Share by Type (2015-2020) |
|
4.4 Global Influenza Virus Vaccine (H1N1) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End |
|
5 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Application |
|
5.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) |
|
5.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2015-2020) |
|
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2015-2020) |
|
6 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business |
|
6.1 Company 1 |
|
| 6.1.1 Corporation Information | |
| 6.1.2 Company 1 Description, Business Overview and Total Revenue | |
| 6.1.3 Company 1 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.1.4 Company 1 Products Offered | |
| 6.1.5 Company 1 Recent Development | |
6.2 Company 2 |
|
| 6.2.1 Company 2 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.2.2 Company 2 Description, Business Overview and Total Revenue | |
| 6.2.3 Company 2 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.2.4 Company 2 Products Offered | |
| 6.2.5 Company 2 Recent Development | |
6.3 Company 3 |
|
| 6.3.1 Company 3 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.3.2 Company 3 Description, Business Overview and Total Revenue | |
| 6.3.3 Company 3 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.3.4 Company 3 Products Offered | |
| 6.3.5 Company 3 Recent Development | |
6.4 Company 4 |
|
| 6.4.1 Company 4 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.4.2 Company 4 Description, Business Overview and Total Revenue | |
| 6.4.3 Company 4 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.4.4 Company 4 Products Offered | |
| 6.4.5 Company 4 Recent Development | |
6.5 Company 5 |
|
| 6.5.1 Company 5 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.5.2 Company 5 Description, Business Overview and Total Revenue | |
| 6.5.3 Company 5 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.5.4 Company 5 Products Offered | |
| 6.5.5 Company 5 Recent Development | |
6.6 Company 6 |
|
| 6.6.1 Company 6 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.6.2 Company 6 Description, Business Overview and Total Revenue | |
| 6.6.3 Company 6 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.6.4 Company 6 Products Offered | |
| 6.6.5 Company 6 Recent Development | |
6.7 Company 7 |
|
| 6.6.1 Company 7 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.6.2 Company 7 Description, Business Overview and Total Revenue | |
| 6.6.3 Company 7 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.4.4 Company 7 Products Offered | |
| 6.7.5 Company 7 Recent Development | |
6.8 Company 8 |
|
| 6.8.1 Company 8 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.8.2 Company 8 Description, Business Overview and Total Revenue | |
| 6.8.3 Company 8 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.8.4 Company 8 Products Offered | |
| 6.8.5 Company 8 Recent Development | |
6.9 Company 9 |
|
| 6.9.1 Company 9 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.9.2 Company 9 Description, Business Overview and Total Revenue | |
| 6.9.3 Company 9 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.9.4 Company 9 Products Offered | |
| 6.9.5 Company 9 Recent Development | |
6.10 Company 10 |
|
| 6.10.1 Company 10 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.10.2 Company 10 Description, Business Overview and Total Revenue | |
| 6.10.3 Company 10 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.10.4 Company 10 Products Offered | |
| 6.10.5 Company 10 Recent Development | |
| 全球流感病毒疫苗（H1N1）行業(yè)深度研究和趨勢分析報告二零二零年至2026年 | |
6.11 Company 11 |
|
| 6.11.1 Company 11 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.11.2 Company 11 Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue | |
| 6.11.3 Company 11 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.11.4 Company 11 Products Offered | |
| 6.11.5 Company 11 Recent Development | |
6.12 Company 12 |
|
| 6.12.1 Company 12 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.12.2 Company 12 Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue | |
| 6.12.3 Company 12 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.12.4 Company 12 Products Offered | |
| 6.12.5 Company 12 Recent Development | |
6.13 Company 13 |
|
| 6.13.1 Company 13 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.13.2 Company 13 Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue | |
| 6.13.3 Company 13 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.13.4 Company 13 Products Offered | |
| 6.13.5 Company 13 Recent Development | |
6.14 Company 14 |
|
| 6.14.1 Company 14 Influenza Virus Vaccine (H1N1) Production Sites and Area Served | |
| 6.14.2 Company 14 Influenza Virus Vaccine (H1N1) Description, Business Overview and Total Revenue | |
| 6.14.3 Company 14 Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2015-2020) | |
| 6.14.4 Company 14 Products Offered | |
| 6.14.5 Company 14 Recent Development | |
7 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis |
|
7.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis |
|
| 7.1.1 Key Raw Materials | |
| 7.1.2 Key Raw Materials Price Trend | |
| 7.1.3 Key Suppliers of Raw Materials | |
7.2 Proportion of Manufacturing Cost Structure |
|
7.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1) |
|
7.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis |
|
8 Marketing Channel, Distributors and Customers |
|
8.1 Marketing Channel |
|
8.2 Influenza Virus Vaccine (H1N1) Distributors List |
|
8.3 Influenza Virus Vaccine (H1N1) Customers |
|
9 Market Dynamics |
|
9.1 Market Trends |
|
9.2 Opportunities and Drivers |
|
9.3 Challenges |
|
9.4 Porter's Five Forces Analysis |
|
10 Global Market Forecast |
|
10.1 Global Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Type |
|
| 10.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2021-2026) | |
| 10.1.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Type (2021-2026) | |
10.2 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Application |
|
| 10.2.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Application (2021-2026) | |
| 10.2.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Application (2021-2026) | |
10.3 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region |
|
| 10.3.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Region (2021-2026) | |
| 10.3.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Region (2021-2026) | |
10.4 North America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) |
|
10.5 Europe Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) |
|
10.6 Asia Pacific Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) |
|
10.7 Latin America Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) |
|
10.8 Middle East and Africa Influenza Virus Vaccine (H1N1) Estimates and Projections (2021-2026) |
|
11 Research Finding and Conclusion |
|
12 Methodology and Data Source |
|
12.1 Methodology/Research Approach |
|
| 12.1.1 Research Programs/Design | |
| 12.1.2 Market Size Estimation | |
| 12.1.3 Market Breakdown and Data Triangulation | |
12.2 Data Source |
|
| 12.2.1 Secondary Sources | |
| 12.2.2 Primary Sources | |
12.3 Author List |
|
12.4 Disclaimer |
|
| List of Tables | |
| Table 1. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate Comparison by Type (2015-2026) | |
| Table 2. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Comparison by Application: 2020 VS 2026 | |
| Table 3. Global Influenza Virus Vaccine (H1N1) Market Size by Type (K Doses) (US$ Million) (2020 VS 2026) | |
| Table 4. Global Key Influenza Virus Vaccine (H1N1) Manufacturers Covered in This Study | |
| Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Manufacturers (2015-2020) | |
| Table 6. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2015-2020) | |
| Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (Million USD) by Manufacturers (2015-2020) | |
| Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2015-2020) | |
| Table 9. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2015-2020) | |
| Table 10. Manufacturers Influenza Virus Vaccine (H1N1) Sales Sites and Area Served | |
| Table 11. Manufacturers Influenza Virus Vaccine (H1N1) Product Types | |
| Table 12. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI) | |
| Table 13. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2019) | |
| Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans | |
| Table 15. Main Points Interviewed from Key Influenza Virus Vaccine (H1N1) Players | |
| Table 16. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Region (2015-2020) | |
| Table 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) | |
| Table 18. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Region (2015-2020) | |
| Table 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) | |
| Table 20. North America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) | |
| Table 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) | |
| Table 22. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) | |
| Table 23. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) | |
| Table 24. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) | |
| Table 25. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) | |
| 全球流感病毒疫苗（H1N1）行業(yè)深度研究和趨勢分析報告二零二零年至2026年 | |
| Table 26. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) | |
| Table 27. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) | |
| Table 28. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2015-2020) (K Doses) | |
| Table 29. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) | |
| Table 30. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2015-2020) (US$ Million) | |
| Table 31. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) | |
| Table 32. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) | |
| Table 33. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) | |
| Table 34. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) | |
| Table 35. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) | |
| Table 36. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2015-2020) (K Doses) | |
| Table 37. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2015-2020) | |
| Table 38. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2015-2020) (US$ Million) | |
| Table 39. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2015-2020) | |
| Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2015-2020) | |
| Table 41. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2015-2020) | |
| Table 42. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Type (2015-2020) | |
| Table 43. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2015-2020) | |
| Table 44. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2015-2020) | |
| Table 45. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2015-2020) | |
| Table 46. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) | |
| Table 47. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate by Application (2015-2020) | |
| Table 48. Company 1 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 49. Company 1 Description and Business Overview | |
| Table 50. Company 1 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 51. Company 1 Main Product | |
| Table 52. Company 1 Recent Development | |
| Table 53. Company 2 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 54. Company 2 Corporation Information | |
| Table 55. Company 2 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 56. Company 2 Main Product | |
| Table 57. Company 2 Recent Development | |
| Table 58. Company 3 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 59. Company 3 Corporation Information | |
| Table 60. Company 3 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 61. Company 3 Main Product | |
| Table 62. Company 3 Recent Development | |
| Table 63. Company 4 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 64. Company 4 Corporation Information | |
| Table 65. Company 4 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 66. Company 4 Main Product | |
| Table 67. Company 4 Recent Development | |
| Table 68. Company 5 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 69. Company 5 Corporation Information | |
| Table 70. Company 5 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 71. Company 5 Main Product | |
| Table 72. Company 5 Recent Development | |
| Table 73. Company 6 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 74. Company 6 Corporation Information | |
| Table 75. Company 6 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 76. Company 6 Main Product | |
| Table 77. Company 6 Recent Development | |
| Table 78. Company 7 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 79. Company 7 Corporation Information | |
| Table 80. Company 7 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 81. Company 7 Main Product | |
| Table 82. Company 7 Recent Development | |
| Table 83. Company 8 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 84. Company 8 Corporation Information | |
| Table 85. Company 8 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 86. Company 8 Main Product | |
| Table 87. Company 8 Recent Development | |
| Table 88. Company 9 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 89. Company 9 Corporation Information | |
| Table 90. Company 9 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 91. Company 9 Main Product | |
| Table 92. Company 9 Recent Development | |
| Table 93. Company 10 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 94. Company 10 Corporation Information | |
| Table 95. Company 10 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 96. Company 10 Main Product | |
| Table 97. Company 10 Recent Development | |
| Table 98. Company 11 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 99. Company 11 Corporation Information | |
| Table 100. Company 11 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 101. Company 11 Main Product | |
| Table 102. Company 11 Recent Development | |
| Table 103. Company 12 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 104. Company 12 Corporation Information | |
| Table 105. Company 12 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 106. Company 12 Main Product | |
| Table 107. Company 12 Recent Development | |
| Table 108. Company 13 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 109. Company 13 Corporation Information | |
| Table 110. Company 13 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 111. Company 13 Main Product | |
| Table 112. Company 13 Recent Development | |
| Table 113. Company 14 Influenza Virus Vaccine (H1N1) Corporation Information | |
| Table 114. Company 14 Corporation Information | |
| Table 115. Company 14 Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020) | |
| Table 116. Company 14 Main Product | |
| Table 117. Company 14 Recent Development | |
| Table 118. Sales Base and Market Concentration Rate of Raw Material | |
| quánqiú liúgǎn bìngdú yìmiáo (H1N1) hángyè shēndù yánjiū hé qūshì fēnxī bàogào èr líng èr líng nián zhì 2026 nián | |
| Table 119. Key Suppliers of Raw Materials | |
| Table 120. Influenza Virus Vaccine (H1N1) Distributors List | |
| Table 121. Influenza Virus Vaccine (H1N1) Customers List | |
| Table 122. Market Key Trends | |
| Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) | |
| Table 124. Key Challenges | |
| Table 125. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Type (2021-2026) | |
| Table 126. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2021-2026) | |
| Table 127. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Type (2021-2026) | |
| Table 128. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Market Share Forecast by Type (2021-2026) | |
| Table 129. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Application (2021-2026) | |
| Table 130. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) Forecast by Application (2021-2026) | |
| Table 131. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Region (2021-2026) | |
| Table 132. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2021-2026) | |
| Table 133. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2021-2026) (US$ Million) | |
| Table 134. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2021-2026) | |
| Table 135. Research Programs/Design for This Report | |
| Table 136. Key Data Information from Secondary Sources | |
| Table 137. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Picture of Influenza Virus Vaccine (H1N1) | |
| Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type: 2020 VS 2026 | |
| Figure 3. Intramuscular Vaccine Product Picture | |
| Figure 4. Nasal Spray Vaccine Product Picture | |
| Figure 5. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Application: 2020 VS 2026 | |
| Figure 6. 3 To 10 Years Old | |
| Figure 7. 10 To 18 Years Old | |
| Figure 8. Above 18 Years Old | |
| Figure 9. Other | |
| Figure 10. Global Influenza Virus Vaccine (H1N1) Market Size 2015-2026 (US$ Million) | |
| Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Capacity (K Doses) (2015-2026) | |
| Figure 12. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region: 2020 Versus 2026 | |
| Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2020 | |
| Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2019 | |
| Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2019 | |
| Figure 16. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 | |
| Figure 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2015-2020) | |
| Figure 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019 | |
| Figure 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2015-2020) | |
| Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019 | |
| Figure 21. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 | |
| Figure 22. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 | |
| Figure 23. U.S. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 24. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 25. Canada Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 26. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 27. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 | |
| Figure 28. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 | |
| Figure 29. Germany Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 30. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 31. France Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 32. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 33. U.K. Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 34. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 35. Italy Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 36. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 37. Russia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 38. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 39. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2019 | |
| Figure 40. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2019 | |
| Figure 41. China Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 42. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 43. Japan Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 44. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 45. South Korea Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 46. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 47. India Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 48. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 49. Australia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 50. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 51. Taiwan, China Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 52. Taiwan, China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 53. Indonesia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 54. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 55. Thailand Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 56. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 57. Malaysia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 58. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 59. Philippines Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 60. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 61. Vietnam Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 62. Vietnam Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 63. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 | |
| Figure 64. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 | |
| Figure 65. Mexico Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 66. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 67. Brazil Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 68. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 69. Argentina Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 70. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 71. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2019 | |
| Figure 72. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2019 | |
| Figure 73. Turkey Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| グローバルインフルエンザウイルスワクチン（H1N1）業(yè)界の深い研究と動向分析レポート2020年から2026年 | |
| Figure 74. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 75. Saudi Arabia Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 76. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 77. UAE Influenza Virus Vaccine (H1N1) Sales Growth Rate (2015-2020) (K Doses) | |
| Figure 78. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2015-2020) (US$ Million) | |
| Figure 79. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020) | |
| Figure 80. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019 | |
| Figure 81. Revenue Share of Influenza Virus Vaccine (H1N1) by Type (2015-2020) | |
| Figure 82. Revenue Market Share of Influenza Virus Vaccine (H1N1) by Type in 2019 | |
| Figure 83. Global Influenza Virus Vaccine (H1N1) Sales Growth by Type (2015-2020) (K Doses) | |
| Figure 84. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2015-2020) | |
| Figure 85. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2019 | |
| Figure 86. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application (2015-2020) | |
| Figure 87. Global Revenue Share of Influenza Virus Vaccine (H1N1) by Application in 2020 | |
| Figure 88. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 89. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 90. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 91. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 92. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 93. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 94. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 95. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 96. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 97. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 98. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 99. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 100. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 101. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 102. Price Trend of Key Raw Materials | |
| Figure 103. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1) | |
| Figure 104. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1) | |
| Figure 105. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis | |
| Figure 106. Channels of Distribution | |
| Figure 107. Distributors Profiles | |
| Figure 108. Porter's Five Forces Analysis | |
| Figure 109. North America Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) | |
| Figure 110. North America Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 111. Europe Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) | |
| Figure 112. Europe Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 113. Latin America Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) | |
| Figure 114. Latin America Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 115. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) | |
| Figure 116. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 117. Asia Pacific Influenza Virus Vaccine (H1N1) Sales (K Doses) and Growth Rate Forecast (2021-2026) | |
| Figure 118. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue (Million US$) and Growth Rate Forecast (2021-2026) | |
| Figure 119. Bottom-up and Top-down Approaches for This Report | |
| Figure 120. Data Triangulation | |
| Figure 121. Key Executives Interviewed | |
略……
如需購買《Global Influenza Virus Vaccine (H1N1) Industry In-Depth Research and Trends Analysis Report 2020-2026》，編號：2739910
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
京公網(wǎng)安備 11010802027365號